Streetbeat News

Equity Actions

COP

CVX

MPC

USO

VLO

XLE

XOM

Crude oil prices surged in Q1 2024, with U.S. and European benchmarks reaching five-month highs due to a tighter supply/demand outlook and global geopolitical concerns. The United States Oil Fund (USO) saw an 18.1% increase, reflecting the rise in U.S. oil prices. Factors contributing to the price increase include OPEC's output curbs, robust U.S. economic data, and geopolitical tensions in Ukraine, Israel, and the Middle East. Energy analysts expect high prices to persist into Q2. Major oil and gas producers and related ETFs like XLE, XOM, COP, CVX, MPC, and VLO also reported significant gains.

Portfolio Pulse from Neil Dennis

April 03, 2024 | 5:05 pm

ELF

16 analysts have recently reviewed e.l.f. Beauty (NYSE:ELF), showing a mix of bullish to bearish sentiments. The average 12-month price target is now $198.75, up 17.17% from the previous $169.62, indicating a positive outlook. e.l.f. Beauty's financial health is strong, with significant revenue growth, high net margin, and excellent ROE and ROA, outperforming industry averages. The company's debt-to-equity ratio is also below the industry average, suggesting a healthy balance between debt and equity.

Portfolio Pulse from Benzinga Insights

April 03, 2024 | 5:00 pm

NRG

NRG Energy announced it will repurchase approximately $251 million of its 2.75% convertible senior notes due 2048, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 4:51 pm

NRG

NRG Energy, Inc. (NYSE:NRG) plans to repurchase approximately $251 million of its 2.75% convertible senior notes due 2048 from certain holders. The repurchases are expected to close by April 18, 2024, leaving around $232 million of these notes outstanding.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 4:36 pm

PLAY

Dave & Buster's Entertainment, Inc. (NASDAQ:PLAY) shares increased after a recent dip due to Q4 results missing expectations. The company reported earnings of $1.03 per share against an estimate of $1.10, and sales of $599.1 million versus an expected $602.609 million. Despite this, the board increased its share repurchase authorization by $100 million to $200 million. Analysts from UBS and Truist Securities maintained their ratings but raised their price targets for PLAY. The stock's rise is also attributed to a high short interest of 17.73%.

Portfolio Pulse from Erica Kollmann

April 03, 2024 | 4:32 pm

DAR

Darling Ingredients (NYSE:DAR) has received mixed evaluations from 8 analysts over the past three months, with a shift towards a more indifferent stance in the last 30 days. The average 12-month price target for DAR has been adjusted to $65.62, down from $74.00, reflecting a decrease in analyst optimism. The company's financial performance shows a revenue decline of -8.71% over the last quarter, a strong net margin of 5.24%, and an ROE of 1.88%, but it carries a high debt-to-equity ratio of 1.01, indicating potential financial challenges.

Portfolio Pulse from Benzinga Insights

April 03, 2024 | 4:01 pm

PAYX

Recent analyst ratings for Paychex (NASDAQ:PAYX) show a consensus of indifference with all 4 analysts giving a neutral rating over the last three months. The average 12-month price target for PAYX has been adjusted to $121.0, reflecting a slight increase from the previous $120.00. Paychex, a leading provider of payroll and human capital management solutions, has shown strong financial performance with a revenue growth rate of 5.68%, a net margin of 31.22%, and an ROE of 11.04%. The company's market capitalization and financial metrics indicate a robust financial health and investor confidence.

Portfolio Pulse from Benzinga Insights

April 03, 2024 | 4:00 pm

ABT

Analyst ratings for Abbott Laboratories (NYSE:ABT) show a positive trend with 7 analysts offering diverse opinions over the last three months. The average 12-month price target has been raised to $129.43 from $125.00, indicating a 3.54% increase. Recent actions by analysts include ratings from 'Buy' to 'Outperform' with price target adjustments reflecting optimism about the company's performance. Abbott's financial metrics such as revenue growth, net margin, ROE, ROA, and debt management are highlighted, showcasing its strong market position and financial health.

Portfolio Pulse from Benzinga Insights

April 03, 2024 | 4:00 pm

APT

Alpha Pro Tech, Ltd. (APT) has announced a $2 million expansion of its share repurchase program, bringing the total available for repurchases to $2.7 million. The company plans to retire all shares bought under this program, with purchases to be made through open market or privately-negotiated transactions, in compliance with SEC rules.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 3:30 pm

SNPX

Synaptogenix announced a 1-for-25 reverse stock split, leading to its shares trading lower.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 3:07 pm